These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 395627)
1. Effect of orally administered 15(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in patients with duodenal ulcers. Konturek SJ; Swierczek JS; Kwiecien N; Obtułowicz W; Sito E; Oleksy J Scand J Gastroenterol; 1979; 14(7):813-9. PubMed ID: 395627 [TBL] [Abstract][Full Text] [Related]
2. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer. Thomas FJ; Koss MA; Hogan DL; Isenberg JI Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654 [TBL] [Abstract][Full Text] [Related]
3. The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients. Peterson W; Feldman M; Taylor I; Bremer M Dig Dis Sci; 1979 May; 24(5):381-4. PubMed ID: 456224 [TBL] [Abstract][Full Text] [Related]
4. Effect of synthetic 15-methyl analog of PGE2 on gastric acid and serum gastrin response to peptone meal, pentagastrin, and histamine in duodenal ulcer patients. Konturek SJ; Oleksy J; Biernat J; Sito E; Kwiecień N Am J Dig Dis; 1976 Apr; 21(4):291-5. PubMed ID: 1274921 [TBL] [Abstract][Full Text] [Related]
5. Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Ippoliti AF; Isenberg JI; Hagie L Gastroenterology; 1981 Jan; 80(1):55-9. PubMed ID: 7450412 [TBL] [Abstract][Full Text] [Related]
7. Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Konturek SJ; Kwiecień N; Swierczek J; Oleksy J; Sito E; Robert A Gastroenterology; 1976 May; 70(5 PT.1):683-7. PubMed ID: 770226 [TBL] [Abstract][Full Text] [Related]
8. Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients. Bianchi Porro G; Imbimbo BP; Lazzaroni M Agents Actions; 1988 Aug; 25(1-2):22-6. PubMed ID: 3055874 [TBL] [Abstract][Full Text] [Related]
15. The effect of 16,16-dimethyl prostaglandin E2 on meal-stimulated gastric acid secretion and serum gastrin in duodenal ulcer patients. Ippoliti AF; Isenberg JI; Maxwell V; Walsh JH Gastroenterology; 1976 Apr; 70(4):488-91. PubMed ID: 1254135 [TBL] [Abstract][Full Text] [Related]
16. Acid and endocrine responses to meals varying in pH in normal and duodenal ulcer subjects. Thompson JC; Swierczek JS Ann Surg; 1977 Oct; 186(4):541-48. PubMed ID: 907397 [TBL] [Abstract][Full Text] [Related]
17. Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally. Robert A; Kane G; Reele SB Gut; 1981 Sep; 22(9):728-31. PubMed ID: 7297921 [TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori. Konturek JW J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215 [TBL] [Abstract][Full Text] [Related]
19. The effect of 15(R)-15-methyl prostaglandin E2 on basal and meal stimulated serum gastrin in duodenal ulcer patients. Tytgat GN; Huibregtse K Prostaglandins; 1981; 21 Suppl():53-6. PubMed ID: 7302260 [TBL] [Abstract][Full Text] [Related]
20. Reversible sustained increase of gastrin and gastric acid secretion in a subgroup of duodenal ulcer patients on long-term treatment with H2 antagonists. Kohn A; Annibale B; Prantera C; Giglio L; Suriano G; Delle Fave G J Clin Gastroenterol; 1991 Jun; 13(3):284-90. PubMed ID: 1676714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]